Oscar Health, Inc. (OSCR) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Oscar Health, Inc. (OSCR) closed at $12.21, marking a +1.5% move from the previous day. The stock's change was more than the S&P 500's daily gain of 0.54%. Elsewhere, the Dow saw an upswing of 0.66%, while the tech-heavy Nasdaq appreciated by 0.77%.

The company's shares have seen a decrease of 2.2% over the last month, surpassing the Finance sector's loss of 5.77% and the S&P 500's loss of 4.71%.

The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. The company's upcoming EPS is projected at $1.21, signifying a 31.52% increase compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $4.89 billion, showing a 60.62% escalation compared to the year-ago quarter.

For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.2 per share and a revenue of $18.91 billion, signifying shifts of +111.83% and +61.62%, respectively, from the last year.

Investors should also take note of any recent adjustments to analyst estimates for Oscar Health, Inc. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As such, positive estimate revisions reflect analyst optimism about the business and profitability.

Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Oscar Health, Inc. is currently a Zacks Rank #3 (Hold).

In the context of valuation, Oscar Health, Inc. is at present trading with a Forward P/E ratio of 59.16. For comparison, its industry has an average Forward P/E of 9.28, which means Oscar Health, Inc. is trading at a premium to the group.

The Insurance - Multi line industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 146, which puts it in the bottom 41% of all 250+ industries.

The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.

Radical New Technology Could Hand Investors Huge Gains

Quantum Computing is the next technological revolution, and it could be even more advanced than AI.

While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.

Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.

Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.

See Top Quantum Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Oscar Health, Inc. (OSCR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research